Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology

Oncogene volume 25, pages 4947–4954 (2006)Cite this article

Abstract

The t(3;14)(q27;q32) is the most common translocation involving BCL6 in B-cell lymphoma. Although this translocation was predominantly associated with diffuse large B-cell lymphoma (DLBCL), recent studies have shown that it can also be found in follicular lymphomas (FL), often associated with a large cell component. To further investigate the relationship that might exist between this translocation and the phenotype of the tumors, we studied 34 lymphomas with a t(3;14)(q27;q32). Twenty cases were DLBCL, 14 FL and most cases, regardless of histology, were negative for the expression of CD10 (26/32, 81%). We identified the IGH switch region involved in the translocation for 32 cases. Our data indicate that in DLBCL most breakpoints involve the switch μ (17/19; 89%), whereas in FL most involve a switch γ (9/13; 70%) (P=0.0016, Fisher's exact test). This correlation between the histology and the structure of the translocated allele suggests that the lymphomas with Sμ and Sγ translocations may originate from different cells, or that the substituted regulatory regions that come to deregulate BCL6 may affect the presentation of the disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Akasaka H, Akasaka T, Kurata M, Ueda C, Shimizu A, Uchiyama T et al. (2000a). Cancer Res 60: 2335–2341.

  • Akasaka T, Lossos IS, Levy R . (2003). Blood 102: 1443–1448.

  • Akasaka T, Ueda C, Kurata M, Akasaka H, Yamabe H, Uchiyama T et al. (2000b). Blood 96: 2907–2909.

  • Barrans SL, O'Connor SJ, Evans PA, Davies FE, Owen RG, Haynes AP et al. (2002). Br J Haematol 117: 322–332.

  • Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezzella F et al. (1994). Blood 83: 2423–2427.

  • Bosga-Bouwer AG, van Imhoff GW, Boonstra R, van d V, Haralambieva E, van den BA et al. (2003). Blood 101: 1149–1154.

  • Butler MP, Iida S, Capello D, Rossi D, Rao PH, Nallasivam P et al. (2002). Cancer Res 62: 4089–4094.

  • Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, Gambacorta M et al. (2000). Blood 95: 2084–2092.

  • Horsman DE, McNeil BK, Anderson M, Shenkier T, Gascoyne RD . (1995). Br J Haematol 89: 569–575.

  • Horsman DE, Okamoto I, Ludkovski O, Le N, Harder L, Gesk S et al. (2003). Br J Haematol 120: 424–433.

  • Islam KB, Baskin B, Christensson B, Hammarstrom L, Smith CI . (1994). Clin Exp Immunol 95: 3–9.

  • Jaffe ES, Harris NL, Stein H, Vardiman J . (2001). Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001.

    Google Scholar 

  • Jardin F, Bastard C, Contentin N, Parmentier F, Picquenot JM, Tilly H et al. (2003). Blood 102: 1872–1876.

  • Jardin F, Buchonnet G, Parmentier F, Contentin N, Lepretre S, Lenain P et al. (2002a). Leukemia 16: 2318–2325.

  • Jardin F, Gaulard P, Buchonnet G, Contentin N, Lepretre S, Lenain P et al. (2002b). Leukemia 16: 2309–2317.

  • Katzenberger T, Ott G, Klein T, Kalla J, Muller-Hermelink HK, Ott MM . (2004). Am J Pathol 165: 481–490.

  • Kawakami K, Miyanishi S, Sonoki T, Nakamura S, Nomura KN, Toniwaki M et al. (2004). Int J Hematol 79: 474–479.

  • Kawamata N, Nakamura Y, Miki T, Sato E, Isobe Y, Furusawa S et al. (1998). Br J Haematol 100: 484–489.

  • Lo CF, Ye BH, Lista F, Corradini P, Offit K, Knowles DM et al. (1994). Blood 83: 1757–1759.

  • Lossos IS, Akasaka T, Martinez-Climent JA, Siebert R, Levy R . (2003). Leukemia 17: 1390–1397.

  • Lossos IS, Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL et al. (2001). Blood 98: 945–951.

  • Mertens F, Johansson M, Mitelman F . (1995). Cancer Genet Cytogenet 83: 176–177.

  • Nagaoka H, Muramatsu M, Yamamura N, Kinoshita K, Honjo T . (2002). J Exp Med 195: 529–534.

  • Neri A, Barriga F, Knowled DM, Magrath IT, Dalla-Favera R . (1988). Proc Natl Acad Sci USA 85: 2748–2752.

  • Offit K, Lo CF, Louie DC, Parsa NZ, Leung D, Portlock C et al. (1994). N Engl J Med 331: 74–80.

  • Otsuki T, Yano T, Clark HM, Bastard C, Kerckaert JP, Jaffe ES et al. (1995). Blood 85: 2877–2884.

  • Ott G, Katzenberger T, Lohr A, Kindelberger S, Rudiger T, Wilhelm M et al. (2002). Blood 99: 3806–3812.

  • Polo JM, Dell'Oso T, Ranuncolo SM, Cerchietti L, Beck D, Da Silva GF et al. (2004). Nat Med 10: 1329–1335.

  • Schaffer A, Cerutti A, Shah S, Zan H, Casali P . (1999). J Immunol 162: 5327–5336.

  • Stavnezer-Nordgren J, Sirlin S . (1986). EMBO J 5: 95–102.

  • Ueda C, Akasaka T, Ohno H . (2002a). Leuk Lymphoma 43: 1375–1381.

  • Ueda C, Uchiyama T, Ohno H . (2002b). Blood 99: 2624–2625.

  • Willis TG, Dyer MJ . (2000). Blood 96: 808–822.

  • Wlodarska I, Mecucci C, Stul M, Michaux L, Pittaluga S, Hernandez JM et al. (1995). Genes Chromosomes Cancer 14: 1–7.

  • Ye BH, Chaganti S, Chang CC, Niu H, Corradini P, Chaganti RS et al. (1995). EMBO J 14: 6209–6217.

Download references

Acknowledgements

This work was supported by grants from the Comité de l'Eure de la Ligue Contre le Cancer.

Author information

Authors and Affiliations

  1. Groupe d'Etude des Proliférations Lymphoïdes, Centre Henri Becquerel, INSERM U614, IFR23, Rouen, France

    P Ruminy, F Jardin, J M Picquenot, F Parmentier, G Buchonnet, C Maisonneuve, H Tilly & C Bastard

  2. Département de Pathologie, INSERM U617, CHU Henri Mondor, Créteil, France

    P Gaulard

Authors
  1. P Ruminy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F Jardin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J M Picquenot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Gaulard
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Parmentier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Buchonnet
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C Maisonneuve
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H Tilly
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C Bastard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Bastard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruminy, P., Jardin, F., Picquenot, J. et al. Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology. Oncogene 25, 4947–4954 (2006). https://doi.org/10.1038/sj.onc.1209512

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209512

Keywords

This article is cited by

Search

Advanced search

Quick links